Pricing Log in Create free account
Friday 6 November 2026 Export HIMS’s income statement to Excel — free account

Hims & Hers Health, Inc.

HIMS Healthcare Drug Manufacturers Specialty & Generic

Hims & Hers Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 59.0% from fiscal 2024.

Revenue
+38.3%
EPS
−294.7%
Free cash flow
+5.09%
Total debt
+40.8%

Quarter to June 2026, against a year earlier

25.43 1.37 +5.69%
Market cap
$5.6B
P/E
0.0×
Fwd P/E
−49.4×
Dividend yield
—
F-score
4/9
Altman Z
4.10
Beneish M
n/a
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Hims & Hers Health, Inc. (HIMS) Current ratio

Alert me on Current ratio

Hims & Hers Health, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 0.9×, down 1.0× from fiscal 2025 (1.9×). Over the past ten years it has ranged from 1.7× (fiscal 2019) to 7.4× (fiscal 2020); the current reading is higher than 36% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 2.4× and below the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 1.9× 6.15%
FY2024 1.8× (40.32%)
FY2023 3.0× (33.69%)
FY2022 4.5× 0.00%
FY2022 4.5× 32.61%
FY2021 3.4× 0.00%
FY2021 3.4× (54.12%)
FY2020 7.4× 3.60%
FY2020 7.2× 323.47%
FY2019 1.7× 0.00%

Quarterly newest first

Period Current ratio Change
Jun 2026 0.9× (44.74%)
Mar 2026 1.7× (11.00%)
Dec 2025 1.9× 1.23%
Sep 2025 1.9× (62.34%)
25 more quarters

Against its own ten years

Low 1.7× High 7.4×
Ten-year median 3.4×
Current reading's percentile 36

Current ratio against peers

Company Current ratio
AMLX Amylyx Pharmaceuticals, Inc. compare 12.1×
KNSA Kiniksa Pharmaceuticals International, plc compare 3.9×
LNTH Lantheus Holdings, Inc. compare 3.2×
ALKS Alkermes plc compare 2.4×
LQDA Liquidia Corporation compare 2.3×
RDY Dr. Reddy's Laboratories Ltd compare 1.9×
AMRX AMNEAL PHARMACEUTICALS, INC. compare 1.9×
HIMS Hims & Hers Health, Inc. 0.9×
SUPN Indivior Pharmaceuticals Inc. compare 0.6×
Drug Manufacturers Specialty & Generic industry median 2.4×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on HIMS